Geographical variation in mortality from systemic lupus erythematosus in the United States

The aim was to identify demographic and environmental factors that affect the incidence and course of systemic lupus erythematosus (SLE) by studying geographical variation in mortality from the disease. Counts of SLE deaths during a 10-y period were determined for each of the 3111 counties in the United States. The counts were subjected to statistical techniques for detecting spatial clusters with significantly higher or lower mortality than expected. Census data were used to compare attributes of the resulting clusters. Four clusters with significantly elevated SLE mortality were identified. They were centered in Alabama, Arkansas, Louisiana and New Mexico and had 41–65% more SLE deaths than expected. Four other clusters with significantly low mortality were centered in Minnesota, Vermont, Virginia and Washington and had 32 ± 44% fewer deaths than expected. Comparison of SLE mortality rates between the New Mexico and Vermont clusters yielded relative risks of 3.2, 3.4 and 5.9 for white, black and other race women, respectively, and of 2.1, 5.2 and ‘undefined’ for white, black and other race men. Census data showed that the clusters with elevated mortality had higher poverty rates and/or greater concentrations of ethnic Hispanics than those with lower mortality. SLE mortality rates show great regional variation within the United States. The variation appears to reflect, in part, geographical patterns in socioeconomic status and in the distribution of persons of Hispanic origin.

[1]  P. Simpson,et al.  Statistical methods in cancer research , 2001, Journal of surgical oncology.

[2]  M. Liang,et al.  Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. , 2000, The Journal of rheumatology.

[3]  J. Reveille,et al.  Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis , 2000 .

[4]  A. Gedalia,et al.  Childhood-onset systemic lupus erythematosus: a comparative study of African Americans and Latin Americans. , 1999, Journal of the National Medical Association.

[5]  G. Sturfelt,et al.  A comparison of genome-scans performed in multicase families with systemic lupus erythematosus from different population groups. , 1999, Journal of autoimmunity.

[6]  N. Goel,et al.  Systemic lupus erythematosus in three ethnic groups: IV. Factors associated with self‐reported functional outcome in a large cohort study , 1999 .

[7]  J. Reveille,et al.  Systemic lupus erythematosus in three ethnic groups: V. Acculturation, health‐related attitudes and behaviors, and disease activity in Hispanic patients from the LUMINA Cohort , 1999 .

[8]  L. Vilá,et al.  Clinical and immunological manifestations in 134 Puerto Rican patients with systemic lupus erythematosus , 1999, Lupus.

[9]  J. Morrison,et al.  Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. , 1999, Human molecular genetics.

[10]  J. Reveille,et al.  Systemic lupus erythematosus in three ethnic groups: III A comparison of characteristics early in the natural history of the LUMINA cohort , 1999 .

[11]  N. Goel,et al.  Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course , 1998 .

[12]  J. Reveille,et al.  Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset , 1998 .

[13]  F. Medina,et al.  Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: relationship with disease duration , 1998, Lupus.

[14]  A. Gharavi,et al.  Ethnic differences in the clinical expression of systemic lupus erythematosus: A comparative study between African-Americans and Latin Americans , 1997, Lupus.

[15]  K. Kilburn Geographic clusters of systemic lupus erythematosus: comment on the review by Wallace and Quismorio. , 1996, Arthritis and rheumatism.

[16]  D. Alarcón-Segovia,et al.  The role of HLA-DR alleles and complotypes through the ethnic barrier in systemic lupus erythematosus in Mexicans , 1996, Lupus.

[17]  D. Wallace,et al.  The elusive search for geographic clusters of systemic lupus erythematosus. Critical review. , 1995, Arthritis and rheumatism.

[18]  D. Gregorio,et al.  Divergent racial trends in mortality from systemic lupus erythematosus. , 1995, The Journal of rheumatology.

[19]  C. Kwoh,et al.  Incidence of systemic lupus erythematosus. Race and gender differences. , 1995, Arthritis and rheumatism.

[20]  S. Wing,et al.  United States mortality from ill-defined causes, 1968-1988: potential effects on heart disease mortality trends. , 1995, International journal of epidemiology.

[21]  M Kulldorff,et al.  Spatial disease clusters: detection and inference. , 1995, Statistics in medicine.

[22]  E. Karlson,et al.  The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus. , 1995, Arthritis and rheumatism.

[23]  F. Arnett,et al.  Major histocompatibility complex class II and C4 alleles in Mexican Americans with systemic lupus erythematosus. , 1995, Tissue antigens.

[24]  S. Studenski,et al.  Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. , 1995, Arthritis and rheumatism.

[25]  M. Doherty,et al.  Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. , 1994, Annals of the rheumatic diseases.

[26]  A. Friede,et al.  CDC WONDER: a comprehensive on-line public health information system of the Centers for Disease Control and Prevention. , 1993, American journal of public health.

[27]  K. Kilburn,et al.  Prevalence of symptoms of systemic lupus erythematosus (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water. , 1992, Environmental research.

[28]  J. Samet,et al.  Symptoms, signs, and ill-defined conditions: a leading cause of death among minorities. , 1990, American journal of epidemiology.

[29]  S. Studenski,et al.  Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences. , 1990, Archives of internal medicine.

[30]  S. Studenski,et al.  Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors. , 1987, Arthritis and rheumatism.

[31]  D. Clayton,et al.  Empirical Bayes estimates of age-standardized relative risks for use in disease mapping. , 1987, Biometrics.

[32]  T. J. Breen,et al.  Biostatistical Analysis (2nd ed.). , 1986 .

[33]  J. Fries,et al.  A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. , 1982, Arthritis and rheumatism.

[34]  W. Hauser,et al.  Epidemiologic features of diffuse connective tissue disorders in Rochester, Minn., 1951 through 1967, with special reference to systemic lupus erythematosus. , 1969, Mayo Clinic proceedings.

[35]  R. Jacox,et al.  The death certificate in rheumatoid arthritis. , 1967, Arthritis and rheumatism.

[36]  A. Masi,et al.  Epidemiology of fatal systemic sclerosis (diffuse scleroderma). A 15-year survey in Baltimore. , 1967, Annals of internal medicine.

[37]  K. Short,et al.  Experimental poverty measures : 1990 to 1997 , 1999 .

[38]  J Thumboo,et al.  Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. , 1999, Arthritis and rheumatism.

[39]  J. Alcocer-Varela,et al.  Haplotype distribution of class II MHC genes in Mexican patients with systemic lupus erythematosus. , 1998, Scandinavian journal of rheumatology.

[40]  M. Liang,et al.  The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[41]  J. Reveille,et al.  Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. , 1990, Arthritis and rheumatism.

[42]  J. Reveille,et al.  Prognosis in systemic lupus erythematosus , 1990 .

[43]  Norman E. Breslow,et al.  The design and analysis of cohort studies , 1987 .

[44]  M. Laakso,et al.  Death certificate and mortality in rheumatoid arthritis. , 1986, Scandinavian journal of rheumatology.

[45]  P. Allebeck,et al.  Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on death certificate. Eleven-year follow-up of an epidemiological study. , 1981, Scandinavian journal of rheumatology.

[46]  Stanley L. Lee,et al.  The epidemiology of systemic lupus erythematosus. , 1973, Seminars in arthritis and rheumatism.

[47]  C Rouquette,et al.  [Epidemiologic research]. , 1970, Bulletin de l'Institut national de la sante et de la recherche medicale.

[48]  T. Leonhardt FAMILY STUDIES IN SYSTEMIC LUPUS ERYTHEMATOSUS. , 1964, Acta medica Scandinavica.